Home
/
ATOSSA THERAPEUTICS, INC.
/
Financials
/
Quarterly
ATOSSA THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ATOSSA THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Sep 30, 2016
$0
Nov 14, 2016
Q2
2016
Jun 30, 2016
$0
Aug 12, 2016
Q1
2016
Mar 31, 2016
$0
May 5, 2016
Q3
2016
Sep 30, 2015
$0
Nov 14, 2016
Q2
2016
Jun 30, 2015
$0
Aug 12, 2016
Q1
2016
Mar 31, 2015
$0
May 5, 2016
Q3
2015
Sep 30, 2014
$3.4K
Nov 12, 2015
Q2
2015
Jun 30, 2014
$9.9K
Aug 6, 2015
Q1
2015
Mar 31, 2014
$24.1K
May 13, 2015
Q3
2014
Sep 30, 2013
$76.6K
Nov 12, 2014
Q2
2014
Jun 30, 2013
$326.1K
Aug 12, 2014
Q1
2014
Mar 31, 2013
$182.7K
May 14, 2014
Q3
2013
Sep 30, 2012
$105.6K
Nov 12, 2013
Q2
2013
Jun 30, 2012
$223.1K
Aug 14, 2013
Q1
2013
Mar 31, 2012
$54.7K
May 15, 2013
Q3
2012
Sep 30, 2011
$0
Jan 22, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.69M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($8.42M)
Aug 12, 2025
Q3
2025
Jun 30, 2025
($8.42M)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($6.72M)
May 13, 2025
Q3
2025
Mar 31, 2025
($6.72M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($6.72M)
Aug 12, 2025
Q3
2025
Sep 30, 2024
($7.23M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($6.05M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($6.05M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($5.88M)
May 13, 2025
Q3
2025
Mar 31, 2024
($5.88M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($5.88M)
Aug 12, 2025
Q3
2024
Sep 30, 2023
($6.23M)
Nov 12, 2024
Q3
2024
Jun 30, 2023
($9.83M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($9.83M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($6.28M)
May 13, 2024
Q2
2024
Mar 31, 2023
($6.28M)
Aug 12, 2024
Q3
2024
Mar 31, 2023
($6.28M)
Nov 12, 2024
Q3
2023
Sep 30, 2022
($8.01M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($6.67M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($9.25M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($9.04M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($7.41M)
May 13, 2025
Q3
2025
Sep 30, 2024
($6.39M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($7.11M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($6.98M)
May 13, 2025
Q3
2024
Sep 30, 2023
($7.47M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($7.79M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($7.10M)
May 13, 2024
Q3
2023
Sep 30, 2022
($8.21M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($6.60M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($4.75M)
May 15, 2023
Q3
2022
Sep 30, 2021
($5.16M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($7.00M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($3.53M)
May 9, 2022
Q3
2021
Sep 30, 2020
($3.51M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($3.94M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($2.94M)
May 14, 2021
Q3
2020
Sep 30, 2019
($3.30M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($7.29M)
Aug 13, 2020